Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial
Year: 2007
Type: article
Source: Annals of Oncology
Institutions: University Hospital Zurich, University of Zurich
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W2159504369
